JoinHealth Spring welcome Webinars 2026
April 2026 - Registration is now open
About
The JoinHealth Spring Series 2026 webinar cycle will take place during April 2026, promoted under DigiHealthPT—a Digital Innovation Hub focused on the healthcare sector:
- 14/04/2026 - PT2030 Funding & Complementary Tax Incentives - REGISTER HERE
- 21/04/2026 - Protection of the Industrial Property in the Digital Health field - REGISTER HERE
- 28/04/2026 - Medical Devices (Pre-)Clinical Development Strategy - REGISTER HERE
The webinars will be held in English, unless all participants speak Portuguese.
Programme
Opening
Health Cluster Portugal
EIT Health Innostars
PT2030 – Framework and Context
- What PT2030 is and how it works.
- Different programs and instruments available to companies.
The “Big 4” of PT2030
- Overview of the four core support typologies.
- How they align with the business life cycle.
Funding Instruments Overview
- R&D (Research & Development).
- Productive Innovation.
- SME Qualification.
- SME Internationalization.
Complementary Tax Incentives
- Key tax incentives that can complement PT2030 funding.
- Important rules and constraints on accumulation.
Key Takeaways & Next Steps
- How to identify the right instrument for your company.
- Practical guidance on preparation and timing.
Speaker: Ana Henriques (Senior Project Manager, IPN)
Q&A Session
Closing remarks
Health Cluster Portugal
EIT Health Innostars
Opening
Health Cluster Portugal
EIT Health Innostars
Industrial Property applied to the digital health fields
- Industrial Property: key concepts.
- Patentability requirements.
- Patents in Digital Health: key considerations and pitfalls.
Intellectual Property Strategies for Digital Health Startups and SMEs
- The relevance of intellectual property for attracting investment, partnerships, and scale-up.
- Industrial property according to the solution’s development stage: relevance and strategic approaches.
- Opportunities and challenges.
Speaker: Alexandra Mendes (Patent Examiner, INPI)
Case study: How Industrial Property can contribute to a company’s success – the Perceive3D case
Alexandra Mendes (Patent Examiner, INPI)
Q&A Session
Closing remarks
Health Cluster Portugal
EIT Health Innostars
Opening
Health Cluster Portugal
EIT Health Innostars
Preclinical evidence behind the guidelines
- What Preclinical Evidence Is Expected - and at What Stage.
- Linking Preclinical Evidence to the General Safety and Performance Requirements (GSPR).
- Usability Studies as Part of Preclinical Evidence.
Speaker: Ana Brito (Coordinator of the Medical Devices Regulatory Support Unit, IPN)
Clinical Evaluation Strategy
- Building a Risk‑Aligned Clinical Evaluation Strategy.
- The Art of Literature: Building a Robust Clinical Evaluation Report (CER).
- Integrating PMS, PMCF and Evidence Generation in a Clinical Evidence Lifecycle.
Speaker: Inês Urbano (Medical Devices Regulatory Affairs Consultant, IPN)
Early clinical validation
- The Sweet Spot: When Early Validation Drives Real Progress.
- ISO 14155 fundamentals for early feasibility and pilot studies.
- Designing high‑quality early clinical studies: Endpoints, Methodology & Scalable Evidence.
Speaker: Maria Nascimento (Testing and Validation Sub-Unit Coordinator, IPN)
Q&A Session
Closing
Health Cluster Portugal
EIT Health Innostars